Bruker Corporation reported third-quarter 2026 revenue of $874.0 million, up 1.6% year over year, with organic revenue growth of 0.7%. Non-GAAP diluted EPS was $0.56, up 24.4%, and non-GAAP operating margin was 16.3%, compared with 12.3% a year earlier. GAAP diluted loss per share was $(0.81), versus $(0.41), and results included a $174.5 million non-cash goodwill impairment charge.
Bruker Scientific Instruments revenue rose 0.8% to $793.9 million, while its organic revenue declined 0.4%; Bruker Energy & Supercon Technologies revenue increased 11.2% to $82.1 million, with organic growth of 11.8% net of intercompany eliminations. For the first nine months, revenue was $2.54 billion, up 3.1%, while organic revenue declined 0.3%; non-GAAP diluted EPS was $1.36 versus $1.23, and GAAP diluted loss per share was $(1.20) versus $(0.25).
Bruker reconfirmed FY2026 revenue guidance of $3.52 billion to $3.56 billion, including organic growth of 1% to 2%, and non-GAAP EPS guidance of $2.10 to $2.15. It expects reported revenue growth of 2.5% to 3.5%, with foreign currency neutral to revenue, compared with a previously expected 0.5% tailwind.
Bruker Corporation’s Board of Directors declared a quarterly cash dividend of $3.9844 per share on its 6.375% Mandatory Convertible Preferred Stock, Series A. Declared October 29, 2026, the dividend is payable December 1, 2026, to shareholders of record at the close of business on November 15, 2026.
Bruker Corp (BRKR) officer Mark Munch, Executive Vice President and President of Bruker Nano Inc., exercised options for 2,000 shares of common stock on September 15, 2026 at an exercise price of $22.19 per share and sold the 2,000 acquired shares at $52.87 per share the same day. The stock option, originally granted on October 4, 2016, fully covered these 2,000 shares and was reported as having no remaining balance after the exercise. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Bruker Corporation (BRKR) reports that officer Mark R. Munch has filed a notice under Rule 144 to sell 2,000 shares of Bruker common stock through Morgan Stanley Smith Barney on NASDAQ. The planned sale has an indicated aggregate market value of $105,740 based on the filing data.
The notice states that Bruker had 152,359,316 shares of common stock outstanding as of September 15, 2026. The filing also lists prior sales by Munch of 2,000 shares on July 15, 2026 and 2,000 shares on August 14, 2026, with reported aggregate values of $120,500 and $115,200, respectively.
BRUKER CORP (BRKR) reported equity compensation awards to officer Burkhard Prause. He received a grant of 3,303 shares of Common Stock in the form of Restricted Stock Units, which vest in equal installments on the first, second, third, and fourth anniversaries of the August 15, 2026 grant date. He was also granted Stock Options for 2,678 shares of Common Stock at an exercise price of $57.70 per share, vesting on the same four annual schedule and expiring on August 15, 2036. Following the Common Stock grant, his directly held Common Stock position is 28,461 shares.
Bruker Corp (BRKR) reported insider equity transactions by Wolfgang Pusch, President BMID Group. On August 17, 2026, he sold 3,473 shares of Common Stock at $56.90 per share. On August 15, 2026, he received equity awards: 3,120 Restricted Stock Units that vest in four equal annual installments, and 2,529 stock options with a $57.70 exercise price, also vesting in four equal annual installments and expiring on August 15, 2036.
BRUKER CORP (symbol: BRKR) is the issuer of record for a Form 4 filing submitted to the SEC.
BRUKER CORP (BRKR) reported that officer Juergen Srega, President CALID, received equity awards. He was granted 16,898 shares of common stock in the form of Restricted Stock Units, which vest in four equal annual installments starting on the first anniversary of the August 15, 2026 grant date, increasing his directly held common shares to 174,625. He was also granted a stock option for 13,698 shares of common stock at an exercise price of $57.70 per share, vesting in four equal annual installments from the same grant date, exercisable from August 15, 2027 until August 15, 2036.
BRUKER CORP (BRKR) reported equity awards and related tax withholding for President & CEO Frank H. Laukien. On August 15, 2026, he received a grant of 71,651 stock options with an exercise price of $63.47 per share, vesting in four equal annual installments starting on the first anniversary of the grant date. He also received 29,463 Restricted Stock Units, which vest in four equal annual installments on the same schedule. On that date, 4,760 common shares were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted RSUs. Indirect holdings include 336,607 common shares held by a daughter.
BRUKER CORP (BRKR) reported equity compensation transactions for Executive Vice President and CFO Gerald N. Herman on August 15, 2026. He received 15,794 shares of Common Stock as Restricted Stock Units that vest in four equal annual installments starting one year after the grant date, and a stock option for 12,803 shares of Common Stock at an exercise price of $63.47 per share, also vesting in four equal annual installments. The option expires on August 15, 2036. On the same date, 2,724 shares of Common Stock were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted restricted stock units.